1 in 20 adults have diabetes — 25 million.

The total number of adults with diabetes is predicted to increase by 142% to 60 million by 2050, the highest percentage increase of all IDF Regions.

4 in 5 (73%) adults with diabetes are undiagnosed, the highest proportion of all IDF Regions.

Diabetes was responsible for 216,000 deaths in 2024

Africa has the lowest diabetes-related expenditure (USD 10 billion) associated with diabetes, 1% of global expenditure.

1 in 7 live births are affected by hyperglycaemia in pregnancy.

Skip Map

Number of adults (20–79 years) with diabetes in Africa (AFR)

2000 2.5 million
2011 14.7 million
2024 24.6 million
2050 59.5 million

Estimates are provided for 49 Sub-Saharan African countries and territories in the IDF Africa (AFR) Region. A total of 35 data sources from 27 countries met the inclusion criteria. About half (45%) of the countries in the Region lack high-quality, in-country data sources. Only three countries (Cape Verde, Gambia and Sao Tome and Principe) had studies conducted within the past five years.

Despite the lowest prevalence estimate of 5.0% among IDF Regions, the expected increase in the number of people with diabetes by 2050 is the highest at 142%, reaching 60 million. The AFR Region is also predicted to have the highest increase in the number of people with impaired glucose tolerance and impaired fasting glucose by 2050, reaching 135 million (138% increase) and 88 million (134% increase) respectively. The proportion of undiagnosed diabetes is also highest of all IDF Regions at 72.6%.

Diabetes care receives the lowest level of investment in the Region, with only 10 billion USD spent on diabetes, representing a mere 1% of the total spent worldwide, despite the Region being home to 11.4% of people with diabetes worldwide.

Download Factsheet

People with diabetes, in 1,000s

Compare regions:

Skip Chart

Age-standardised prevalence of diabetes, %

Compare regions:

Skip Chart

At a glance

Africa

Select a region to compare with:

Clear filter
2000
2011
2024
2050
Loading...
Diabetes estimates (20-79 y)
People with diabetes, in 1,000s 2,532.9 14,700.0 24,585.6 59,526.5
Age-standardised prevalence of diabetes, % 1.2 4.5 5.0 5.9
Proportion of people with undiagnosed diabetes, % - - 72.6 -
People with undiagnosed diabetes, in 1,000s - - 17,860.0 -
Impaired Fasting Glucose (IFG)
People with IFG, in 1,000s - - 37,617.8 88,137.6
Age-standardised prevalence of IFG, % - - 6.6 7.4
Impaired Glucose Tolerance (IGT)
People with IGT, in 1,000s - 32,800.0 56,811.6 135,052.9
Age-standardised prevalence of IGT, % - 9.7 11.5 13.7
Mortality attributable to diabetes (20-79 y)
Deaths attributable to diabetes - 344,500.0 215,836.1 -
Proportion of diabetes-related deaths in people 20-79 y, % - - 4.0 -
Hyperglycaemia in pregnancy (HIP) (20-49 y)
Live births affected by HIP - - 4,669,138.6 -
Prevalence of gestational diabetes mellitus (GDM), % - - 10.8 -
Live births affected by other types of diabetes first detected in pregnancy - - 748,278.1 -
Live births affected by other types of diabetes detected prior to pregnancy - - 286,320.0 -
Diabetes-related health expenditure
Total diabetes-related health expenditure, USD million - 2,800.0 9,931.9 17,972.7
Total diabetes-related health expenditure, ID million - - 33,309.2 63,888.4
Diabetes-related health expenditure per person, USD - 762.7 414.3 310.2
Diabetes-related health expenditure per person, ID - - 1,389.5 1,102.6
Type 1 diabetes estimates in children and adolescents
People with type 1 diabetes (all age groups) - - 351,955.0 -
People with type 1 diabetes (0-19 y) 9,500.0 - 98,163.0 -
Demographics
Total adult population (20-79 y), in 1,000s 217,888.0 387,000.0 581,299.6 1,194,944.7
Population of children and adolescents (0-19 y) - - 640,672,663.0 -
Loading...
Diabetes estimates (20-79 y)
People with diabetes, in 1,000s 2,532.9
Age-standardised prevalence of diabetes, % 1.2
Proportion of people with undiagnosed diabetes, % -
People with undiagnosed diabetes, in 1,000s -
Impaired Fasting Glucose (IFG)
People with IFG, in 1,000s -
Age-standardised prevalence of IFG, % -
Impaired Glucose Tolerance (IGT)
People with IGT, in 1,000s -
Age-standardised prevalence of IGT, % -
Mortality attributable to diabetes (20-79 y)
Deaths attributable to diabetes -
Proportion of diabetes-related deaths in people 20-79 y, % -
Hyperglycaemia in pregnancy (HIP) (20-49 y)
Live births affected by HIP -
Prevalence of gestational diabetes mellitus (GDM), % -
Live births affected by other types of diabetes first detected in pregnancy -
Live births affected by other types of diabetes detected prior to pregnancy -
Diabetes-related health expenditure
Total diabetes-related health expenditure, USD million -
Total diabetes-related health expenditure, ID million -
Diabetes-related health expenditure per person, USD -
Diabetes-related health expenditure per person, ID -
Type 1 diabetes estimates in children and adolescents
People with type 1 diabetes (all age groups) -
People with type 1 diabetes (0-19 y) 9,500.0
Demographics
Total adult population (20-79 y), in 1,000s 217,888.0
Population of children and adolescents (0-19 y) -